Haemonetics Corp.

HAE

Market Cap$4.45B

Close$

Compare Haemonetics

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
Haemonetics Corp.	35.2	0%	13%	3.6	0.9
Market Avg	58.9	1.29%	29%	-	1
Healthcare Avg	66.3	1.31%	15%	-	0.9

$102.86

Current Fair Value

13% upside

Undervalued by 13% based on the discounted cash flow analysis.

Share Statistics

Market cap	$4.45 Billion
Enterprise Value	$5.13 Billion
Dividend Yield	$0.0 (0.0%)
Earnings per Share	$2.46
Beta	0.0
Outstanding Shares	50,786,117
Avg 30 Day Volume	422,638

Return

Return on Equity	-
Return on Assets	-
Return on Invested Capital	-

Valuation & Multiples

P/E Ratio	35.17
PEG	-680.4
Price to Sales	3.64
Price to Book Ratio	5.06
Enterprise Value to Revenue	4.04
Enterprise Value to EBIT	28.39
Enterprise Value to Net Income	40
Total Debt to Enterprise	0.17
Debt to Equity	0.92

Revenue Sources

No data

ESG Score

No data

About Haemonetics Corp.

CEO: Christopher Simon